S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Don't Be Fooled by These 3 Value Traps
The Bottom Is In For McCormick & Company
Modern Day Options Trading For Beginners! (Ad)pixel
Buffett's company owns nearly 24% of Occidental Petroleum
3 Undervalued Dividend Payers For Volatile Market Conditions
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Don't Be Fooled by These 3 Value Traps
The Bottom Is In For McCormick & Company
Modern Day Options Trading For Beginners! (Ad)pixel
Buffett's company owns nearly 24% of Occidental Petroleum
3 Undervalued Dividend Payers For Volatile Market Conditions
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Don't Be Fooled by These 3 Value Traps
The Bottom Is In For McCormick & Company
Modern Day Options Trading For Beginners! (Ad)pixel
Buffett's company owns nearly 24% of Occidental Petroleum
3 Undervalued Dividend Payers For Volatile Market Conditions
S&P 500   3,971.27
DOW   32,394.25
QQQ   307.12
Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story
Modern Day Options Trading For Beginners! (Ad)pixel
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Roku And The 20% Rally That’s About To Start 
Modern Day Options Trading For Beginners! (Ad)pixel
Don't Be Fooled by These 3 Value Traps
The Bottom Is In For McCormick & Company
Modern Day Options Trading For Beginners! (Ad)pixel
Buffett's company owns nearly 24% of Occidental Petroleum
3 Undervalued Dividend Payers For Volatile Market Conditions
NYSE:CO

Global Cord Blood - CO Stock Forecast, Price & News

$2.99
0.00 (0.00%)
(As of 03/28/2023 12:00 AM ET)
Add
Compare
Today's Range
$2.99
$2.99
50-Day Range
$2.99
$2.99
52-Week Range
$2.03
$5.50
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
4.67
Dividend Yield
N/A
Price Target
N/A

CO stock logo

About Global Cord Blood (NYSE:CO) Stock

Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. It provides cord blood processing and storage service. The company also offers cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services. The firm preserves cord blood units donated by the public and provides matching services on such donated units and deliver matching units to patients in need of transplants. Global Cord Blood was founded on January 17, 2008 and is headquartered in Hong Kong.

Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Stock News Headlines

My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
My No. 1 dividend stock for a LIFETIME of income.
Few people realize this… But dividends account for up to 90% of the stock market's returns over the past century!  I think it's a crying shame folks don't know how powerful dividends are.
StockNews.com Begins Coverage on Global Cord Blood (NYSE:CO)
See More Headlines
Receive CO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Cord Blood and its competitors with MarketBeat's FREE daily newsletter.

CO Company Calendar

Last Earnings
6/26/2018
Today
3/29/2023
Fiscal Year End
3/31/2023
Next Earnings (Estimated)
4/03/2023

Industry, Sector and Symbol

Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Employees
1,202
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$196.12 million
Cash Flow
$0.71 per share
Book Value
$6.34 per share

Miscellaneous

Free Float
N/A
Optionable
Optionable
Beta
-0.04

Key Executives

  • Ting Zheng
    Chairman & Chief Executive Officer
  • Bing Chuen Chen
    Chief Financial Officer & Director
  • Xin Xu
    Chief Technology Officer
  • Rui Arashiyama
    CEO-Guangdong & Zhejiang Divisions













CO Stock - Frequently Asked Questions

How have CO shares performed in 2023?

Global Cord Blood's stock was trading at $2.9876 at the beginning of 2023. Since then, CO shares have increased by 0.0% and is now trading at $2.9876.
View the best growth stocks for 2023 here
.

When is Global Cord Blood's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 3rd 2023.
View our CO earnings forecast
.

How were Global Cord Blood's earnings last quarter?

Global Cord Blood Co. (NYSE:CO) posted its earnings results on Tuesday, June, 26th. The medical research company reported $0.04 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.09. The medical research company had revenue of $37.14 million for the quarter.

What other stocks do shareholders of Global Cord Blood own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Cord Blood investors own include AbbVie (ABBV), Fate Therapeutics (FATE), Gilead Sciences (GILD), Rigel Pharmaceuticals (RIGL), Spero Therapeutics (SPRO), Vertex Pharmaceuticals (VRTX), Enphase Energy (ENPH), Galectin Therapeutics (GALT), Intel (INTC) and Marvell Technology (MRVL).

What is Global Cord Blood's stock symbol?

Global Cord Blood trades on the New York Stock Exchange (NYSE) under the ticker symbol "CO."

Who are Global Cord Blood's major shareholders?

Global Cord Blood's stock is owned by a variety of institutional and retail investors. Top institutional investors include Moneta Group Investment Advisors LLC (0.00%), Susquehanna International Group LLP (0.00%), Simplex Trading LLC (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
View institutional ownership trends
.

How do I buy shares of Global Cord Blood?

Shares of CO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Cord Blood's stock price today?

One share of CO stock can currently be purchased for approximately $2.99.

How many employees does Global Cord Blood have?

The company employs 1,202 workers across the globe.

How can I contact Global Cord Blood?

Global Cord Blood's mailing address is 48 FL. BANK OF CHINA TOWER 1 GARDEN ROAD, HONG KONG K3, . The official website for the company is www.globalcordbloodcorp.com. The medical research company can be reached via phone at (523) 605-8180, via email at ir@globalcordbloodcorp.com, or via fax at 852-3605-8181.

This page (NYSE:CO) was last updated on 3/29/2023 by MarketBeat.com Staff